Skip to main content
Skip to section navigation
Skip to footer
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.
NASDAQ:LEXX; NASDAQ WARRANT:LEXXW
Toggle menu
Home
About
Management
Board of Directors
Advisors & Consultants
Technology
Overview
Commercial Applications
Research
Patent Portfolio
Licensing Opportunities
Investors
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Presentations
Company Info
Overview
Management Team
Contacts
2023 Annual General Meeting
2023 Special Meeting
FAQ
Analyst Coverage
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
SEDAR+
Legend Removal
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
3
4
4/A
424B3
424B4
424B5
8-A12B
8-A12G
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DRS
EFFECT
NT 10-K
NTN 10K
POS AM
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Date
Form
Description
PDF
XBRL
Pages
03/08/22
4
Statement of changes in beneficial ownership of securities
2
03/08/22
4
Statement of changes in beneficial ownership of securities
2
03/08/22
4
Statement of changes in beneficial ownership of securities
2
02/14/22
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3
02/14/22
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
02/04/22
EFFECT
Notice of Effectiveness
1
02/02/22
8-K
Current report filing
Documents
expand_more
EX-99.1
12
02/01/22
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
02/01/22
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
1
01/28/22
S-3
Registration statement for specified transactions by certain issuers
Documents
expand_more
EX-5.1
EX-23.1
31
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
…
Page
96
Next Page
arrow_forward
Email Alerts
Contacts
RSS News Feed
Back to the top